Protagen Raises $12.7M to Support Protein Array Diagnostic Development
September 07, 2010
Protagen Raises $12.7M to Support Protein Array Diagnostic Development
The company said it will use the proceeds to expand its diagnostics business unit and to develop serum-based assays for the early detection of multiple sclerosis and prostate cancer.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Protagen to Use UniArray Platform to Discover Multiple Sclerosis Biomarkers for Biogen Idec
March 29, 2011 / BioArray News - Protagen Raises $5.3M to Fund Platform Expansion, Dx Programs
August 4, 2009 / BioArray News - Scienion to Manufacture Protein Arrays for Protagen
April 19, 2011 / BioArray News - Protagen to ID Protein Biomarkers in Support of Biogen's MS Drug Development Work
April 1, 2011 / ProteoMonitor - Protagen Secures Nearly $13M in Funding for Diagnostics Work and Protein Biomarker Validation
September 10, 2010 / ProteoMonitor